<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of SB1907</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					SB1907 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>SB1907</pre></b></center><p> </p>Introduced 2/6/2025, by Sen. Mike Simmons<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>New Act</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>5 ILCS 140/7.5</code></td><td class="synopsis"></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Creates the Access to Prescription Drugs Act. Provides that any State </code><code>agency may enter into partnerships to increase competition, lower prices, </code><code>and address shortages in the market for generic prescription drugs; to </code><code>reduce the cost of prescription drugs for public and private purchasers, </code><code>taxpayers, and consumers; and to increase patient access to affordable </code><code>drugs. Requires the partnerships to result in the production or </code><code>distribution of generic prescription drugs with the intent that these </code><code>drugs be made widely available to public and private purchasers, providers </code><code>and suppliers, and pharmacies. Provides that the State agency shall comply </code><code>with specified requirements when entering into partnerships or setting </code><code>prices for generic prescription drugs. Requires a State agency that elects </code><code>to enter into a partnership under the Act to submit separate reports to the </code><code>General Assembly that (1) assess the feasibility of directly manufacturing </code><code>generic prescription drugs and selling generic prescription drugs at a </code><code>fair price; and (2) describe the status of all drugs targeted under the Act </code><code>and analyze how the activities of the State agency may impact competition, </code><code>access to targeted drugs, the costs of those drugs, and the costs of </code><code>generic prescription drugs to public and private purchasers. Contains </code><code>other provisions. Amends the Freedom of Information Act to exempt certain </code><code>information disclosed under Access to Prescription Drugs Act from </code><code>inspection and copying under the Act. Contains a severability provision. </code><code>Effective July 1, 2025.</code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning health.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 1. </code><code>Short title. </code><code>This Act may be cited as the </code><code>Access </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>to Prescription Drugs Act.</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>Definitions. </code><code>In this Act:</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Department" means any State agency.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Eligible prescription drug" means a prescription drug </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>that is not under patent or a biological product, as defined in </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>42 U.S.C. 262(i), that is not under patent.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Generic prescription drug" means a drug that is approved </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>pursuant to an application referencing an eligible </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>prescription drug that is submitted under subsection (j) of </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>Section 505 of the Federal Food, Drug, and Cosmetic Act (21 </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>U.S.C. 355(j)) or under subsection (k) of Section 351 of the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>federal Public Health Service Act (42 U.S.C. 262(k)).</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Partnerships" includes, but is not limited to, agreements </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>for the procurement of generic prescription drugs by way of </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>contracts or purchasing by a payor, State governmental agency, </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>group purchasing organization, nonprofit organization, or </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>other entity.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Provider" means a hospital licensed under the Hospital </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>Licensing Act or organized under the University of Illinois </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>Hospital Act, a skilled nursing facility as that term is </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>defined under Section 2 of the Comprehensive Health Insurance </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>Plan Act, a comprehensive outpatient rehabilitation facility, </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>a home health agency as that term is defined under Section 2.04 </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>of the Home Health, Home Services, and Home Nursing Agency </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Licensing Act, a hospice as that term is defined under Section </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>2 of the Comprehensive Health Insurance Plan Act, a public </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>health clinic as that term is defined under Section 6-101 of </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>the Local Governmental and Governmental Employees Tort </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>Immunity Act, or a rehabilitation agency.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Supplier" means a physician, surgeon, or other health </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>care practitioner or an entity other than a provider that </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>furnishes health care services.</code><br> </td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 10. </code><code>Cost of prescription drugs; partnerships.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) A department may enter into partnerships consistent </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>with subsection (b) of Section 15, in consultation with other </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>State agencies as necessary, to increase competition, lower </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>prices, and address shortages in the market for generic </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>prescription drugs, reduce the cost of generic prescription </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>drugs for public and private purchasers, taxpayers, and </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>consumers, and increase patient access to affordable generic </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>prescription drugs.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) Subject to appropriation by the General Assembly for </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>this purpose, the department may hire staff to oversee and </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>project-manage the partnerships for manufacturing or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>distribution of generic prescription drugs. </code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 15. </code><code>Generic prescription drug prices.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) A department may enter into partnerships resulting in </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>the production or distribution of generic prescription drugs </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>with the intent that these generic prescription drugs be made </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>widely available to public and private purchasers, providers </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>and suppliers, and pharmacies licensed under the Pharmacy </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>Practice Act, as appropriate. The generic prescription drugs </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>shall be produced or distributed by a drug company or generic </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>prescription drug manufacturer that is registered with the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>United States Food and Drug Administration.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) A department shall comply with the following </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>requirements when entering into partnerships or setting prices </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>for generic prescription drugs: </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) A department shall only enter into partnerships </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>under subsection (a) to produce a generic prescription </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>drug at a price that results in savings, target failures </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>in the market for generic prescription drugs, and improve </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>patient access to affordable medications.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) For generic prescription drugs prioritized in </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>accordance with the criteria listed in paragraph (5), the </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>department shall determine if viable pathways exist for </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>partnerships to manufacture or distribute generic </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>prescription drugs by examining the relevant legal, </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>market, policy, and regulatory factors.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) A department shall consider the following, if </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>applicable, when setting the price of a generic </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>prescription drug under this Section: </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) United States Food and Drug Administration </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >        <code>user fees.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) Abbreviated new drug application acquisition </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >        <code>costs, amortized over a 5-year period.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(C) Mandatory rebates.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(D) Total contracting and production costs for the </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >        <code>generic prescription drug, including a reasonable </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >        <code>amount for administrative, operating, and </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >        <code>rate-of-return expenses of the drug company or generic </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >        <code>prescription drug manufacturer.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(E) Research and development costs attributed to </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >        <code>the generic prescription drug over a 5-year period.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(F) Other initial start-up costs, amortized over a </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >        <code>5-year period. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) Each generic prescription drug shall be made </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>available to providers, patients, and purchasers at a </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>transparent price and without rebates, other than </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>federally required rebates.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) A department shall prioritize the selection of </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>generic prescription drugs that have the greatest impact </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>on lowering drug costs to patients, increasing competition </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>and addressing shortages in the prescription drug market, </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>improving public health, or reducing the cost of </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>prescription drugs to public and private purchasers.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) In identifying generic prescription drugs to be </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>produced, a department shall consider pharmacy spending data </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>from Medicaid and other entities for which the State pays the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>cost of generic prescription drugs.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>The partnerships entered into under subsection (a) shall </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>include the production of at least one form of insulin, if a </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>viable pathway for manufacturing a more affordable form of </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>insulin exists.</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>A department shall prioritize generic prescription drugs </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>for chronic and high-cost conditions and shall consider </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>prioritizing those that can be delivered through mail order.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) A department shall consult with all of the following </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>public and private purchasers to assist in developing a list </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>of generic prescription drugs to be manufactured or </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>distributed through partnerships and to determine the volume </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>of each generic prescription drug that can be procured over a </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>multiyear period to support a market for a lower-cost generic </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>prescription drug:</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) Any public agency that is a purchaser.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) Health insurers holding a valid outstanding </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>certificate of authority from the Director of Insurance.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) Hospitals.</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) Pharmacy benefit managers. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) Before entering into a partnership under subsection </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>(a), a department shall determine minimum thresholds for </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>procurement of an entity's expected volume of a targeted </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>generic prescription drug from the company or manufacturer </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>over a multiyear period.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) The entities listed in paragraphs (2) through (5) of </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>subsection (d) shall not be required to purchase prescription </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>drugs from the department or from entities that contract or </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>partner with the department under this Act.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) A department is not required to consult with every </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>entity listed in paragraphs (2) through (5) of subsection (d) </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>so long as purchaser engagement includes a reasonable </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>representation from those groups.</code><br> </td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 20. </code><code>Feasibility report.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) On or before July 1, 2027, any department that elects </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>to enter into a partnership under this Act shall submit a </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>report to the General Assembly that assesses the feasibility </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>of the department directly manufacturing generic prescription </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>drugs and selling generic prescription drugs at a fair price. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>The report shall include an analysis of governance structure </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>options for manufacturing functions, including chartering a </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>private organization, public-private partnership, or public </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>board of directors.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) This Section is repealed on January 1, 2029. </code><br> </td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 25. </code><code>Status and analysis report.</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) On or before July 1, 2026, any department that elects </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 7 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>to enter into a partnership under this Act shall submit a </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>report to the General Assembly with:</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) a description of the status of all drugs targeted </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>under this Act; and</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) an analysis of how the activities of the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>department may impact competition, access to targeted </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>drugs, the costs of those drugs, and the costs of generic </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>prescription drugs for public and private purchasers.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) This Section is repealed on January 1, 2030.</code><br> </td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 30. </code><code>Nonpublic information; disclosure. </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>Notwithstanding any other provision of law, all nonpublic </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>information and documents obtained under this Act shall not be </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>required to be disclosed under the Freedom of Information Act.</code><br> </td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 35. </code><code>The Freedom of Information Act is amended by </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>changing Section 7.5 as follows:</code><br> </td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(5 ILCS 140/7.5)</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 7.5. </code><code>Statutory exemptions. </code><code>To the extent provided for </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>by the statutes referenced below, the following shall be </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>exempt from inspection and copying:</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(a) All information determined to be confidential </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>under Section 4002 of the Technology Advancement and </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Development Act.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(b) Library circulation and order records identifying </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 8 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>library users with specific materials under the Library </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>Records Confidentiality Act.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(c) Applications, related documents, and medical </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>records received by the Experimental Organ Transplantation </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>Procedures Board and any and all documents or other </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>records prepared by the Experimental Organ Transplantation </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Procedures Board or its staff relating to applications it </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>has received.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(d) Information and records held by the Department of </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>Public Health and its authorized representatives relating </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>to known or suspected cases of sexually transmitted </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>infection or any information the disclosure of which is </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>restricted under the Illinois Sexually Transmitted </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Infection Control Act.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(e) Information the disclosure of which is exempted </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>under Section 30 of the Radon Industry Licensing Act.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(f) Firm performance evaluations under Section 55 of </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>the Architectural, Engineering, and Land Surveying </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>Qualifications Based Selection Act.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(g) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>and exempted under Section 50 of the Illinois Prepaid </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Tuition Act.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(h) Information the disclosure of which is exempted </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>under the State Officials and Employees Ethics Act, and </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>records of any lawfully created State or local inspector </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>general's office that would be exempt if created or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 9 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>obtained by an Executive Inspector General's office under </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>that Act.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(i) Information contained in a local emergency energy </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>plan submitted to a municipality in accordance with a </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>local emergency energy plan ordinance that is adopted </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>under Section 11-21.5-5 of the Illinois Municipal Code.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(j) Information and data concerning the distribution </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>of surcharge moneys collected and remitted by carriers </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>under the Emergency Telephone System Act.</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(k) Law enforcement officer identification information </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>or driver identification information compiled by a law </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>enforcement agency or the Department of Transportation </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>under Section 11-212 of the Illinois Vehicle Code.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(l) Records and information provided to a residential </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>health care facility resident sexual assault and death </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>review team or the Executive Council under the Abuse </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>Prevention Review Team Act.</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(m) Information provided to the predatory lending </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>database created pursuant to Article 3 of the Residential </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>Real Property Disclosure Act, except to the extent </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>authorized under that Article.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(n) Defense budgets and petitions for certification of </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>compensation and expenses for court appointed trial </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>counsel as provided under Sections 10 and 15 of the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>Capital Crimes Litigation Act (repealed). This subsection </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>(n) shall apply until the conclusion of the trial of the </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 10 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>case, even if the prosecution chooses not to pursue the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>death penalty prior to trial or sentencing.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(o) Information that is prohibited from being </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>disclosed under Section 4 of the Illinois Health and </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>Hazardous Substances Registry Act.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(p) Security portions of system safety program plans, </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>investigation reports, surveys, schedules, lists, data, or </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>information compiled, collected, or prepared by or for the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>Department of Transportation under Sections 2705-300 and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>2705-616 of the Department of Transportation Law of the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>Civil Administrative Code of Illinois, the Regional </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Transportation Authority under Section 2.11 of the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>Regional Transportation Authority Act, or the St. Clair </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>County Transit District under the Bi-State Transit Safety </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>Act (repealed). </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(q) Information prohibited from being disclosed by the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>Personnel Record Review Act. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(r) Information prohibited from being disclosed by the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>Illinois School Student Records Act. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(s) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>under Section 5-108 of the Public Utilities Act. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(t) (Blank). </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(u) Records and information provided to an independent </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>team of experts under the Developmental Disability and </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>Mental Health Safety Act (also known as Brian's Law). </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(v) Names and information of people who have applied </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 11 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>for or received Firearm Owner's Identification Cards under </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>the Firearm Owners Identification Card Act or applied for </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>or received a concealed carry license under the Firearm </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Concealed Carry Act, unless otherwise authorized by the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>Firearm Concealed Carry Act; and databases under the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>Firearm Concealed Carry Act, records of the Concealed </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Carry Licensing Review Board under the Firearm Concealed </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>Carry Act, and law enforcement agency objections under the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>Firearm Concealed Carry Act. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(v-5) Records of the Firearm Owner's Identification </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>Card Review Board that are exempted from disclosure under </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Section 10 of the Firearm Owners Identification Card Act.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(w) Personally identifiable information which is </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>exempted from disclosure under subsection (g) of Section </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>19.1 of the Toll Highway Act.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(x) Information which is exempted from disclosure </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>under Section 5-1014.3 of the Counties Code or Section </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>8-11-21 of the Illinois Municipal Code. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(y) Confidential information under the Adult </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>Protective Services Act and its predecessor enabling </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>statute, the Elder Abuse and Neglect Act, including </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>information about the identity and administrative finding </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>against any caregiver of a verified and substantiated </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>decision of abuse, neglect, or financial exploitation of </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>an eligible adult maintained in the Registry established </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>under Section 7.5 of the Adult Protective Services Act. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 12 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(z) Records and information provided to a fatality </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>review team or the Illinois Fatality Review Team Advisory </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>Council under Section 15 of the Adult Protective Services </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(aa) Information which is exempted from disclosure </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>under Section 2.37 of the Wildlife Code. </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(bb) Information which is or was prohibited from </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>disclosure by the Juvenile Court Act of 1987. </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(cc) Recordings made under the Law Enforcement </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>Officer-Worn Body Camera Act, except to the extent </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>authorized under that Act.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(dd) Information that is prohibited from being </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>disclosed under Section 45 of the Condominium and Common </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Interest Community Ombudsperson Act. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ee) Information that is exempted from disclosure </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>under Section 30.1 of the Pharmacy Practice Act. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ff) Information that is exempted from disclosure </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>under the Revised Uniform Unclaimed Property Act. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(gg) Information that is prohibited from being </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>disclosed under Section 7-603.5 of the Illinois Vehicle </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>Code. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(hh) Records that are exempt from disclosure under </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>Section 1A-16.7 of the Election Code. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ii) Information which is exempted from disclosure </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>under Section 2505-800 of the Department of Revenue Law of </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>the Civil Administrative Code of Illinois. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 13 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(jj) Information and reports that are required to be </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>submitted to the Department of Labor by registering day </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>and temporary labor service agencies but are exempt from </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>disclosure under subsection (a-1) of Section 45 of the Day </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>and Temporary Labor Services Act. </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(kk) Information prohibited from disclosure under the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Seizure and Forfeiture Reporting Act. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ll) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>and exempted under Section 5-30.8 of the Illinois Public </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>Aid Code. </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(mm) Records that are exempt from disclosure under </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Section 4.2 of the Crime Victims Compensation Act. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(nn) Information that is exempt from disclosure under </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Section 70 of the Higher Education Student Assistance Act. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(oo) Communications, notes, records, and reports </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>arising out of a peer support counseling session </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>prohibited from disclosure under the First Responders </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>Suicide Prevention Act. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(pp) Names and all identifying information relating to </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>an employee of an emergency services provider or law </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>enforcement agency under the First Responders Suicide </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Prevention Act. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(qq) Information and records held by the Department of </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>Public Health and its authorized representatives collected </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>under the Reproductive Health Act. </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(rr) Information that is exempt from disclosure under </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 14 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>the Cannabis Regulation and Tax Act. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ss) Data reported by an employer to the Department of </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>Human Rights pursuant to Section 2-108 of the Illinois </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Human Rights Act.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(tt) Recordings made under the Children's Advocacy </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>Center Act, except to the extent authorized under that </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(uu) Information that is exempt from disclosure under </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>Section 50 of the Sexual Assault Evidence Submission Act. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(vv) Information that is exempt from disclosure under </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>subsections (f) and (j) of Section 5-36 of the Illinois </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Public Aid Code. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ww) Information that is exempt from disclosure under </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Section 16.8 of the State Treasurer Act. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(xx) Information that is exempt from disclosure or </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>information that shall not be made public under the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>Illinois Insurance Code. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(yy) Information prohibited from being disclosed under </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>the Illinois Educational Labor Relations Act.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(zz) Information prohibited from being disclosed under </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>the Illinois Public Labor Relations Act. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(aaa) Information prohibited from being disclosed </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>under Section 1-167 of the Illinois Pension Code. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(bbb) Information that is prohibited from disclosure </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>by the Illinois Police Training Act and the Illinois State </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>Police Act. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 15 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ccc) Records exempt from disclosure under Section </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>2605-304 of the Illinois State Police Law of the Civil </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>Administrative Code of Illinois. </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ddd) Information prohibited from being disclosed </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>under Section 35 of the Address Confidentiality for </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>Victims of Domestic Violence, Sexual Assault, Human </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Trafficking, or Stalking Act. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(eee) Information prohibited from being disclosed </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>under subsection (b) of Section 75 of the Domestic </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>Violence Fatality Review Act. </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(fff) Images from cameras under the Expressway Camera </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Act. This subsection (fff) is inoperative on and after </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>July 1, 2025. </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ggg) Information prohibited from disclosure under </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>paragraph (3) of subsection (a) of Section 14 of the Nurse </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>Agency Licensing Act. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(hhh) Information submitted to the Illinois State </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>Police in an affidavit or application for an assault </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>weapon endorsement, assault weapon attachment endorsement, </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>.50 caliber rifle endorsement, or .50 caliber cartridge </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>endorsement under the Firearm Owners Identification Card </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(iii) Data exempt from disclosure under Section 50 of </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>the School Safety Drill Act. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(jjj) Information exempt from disclosure under Section </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>30 of the Insurance Data Security Law. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 16 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(kkk) Confidential business information prohibited </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>from disclosure under Section 45 of the Paint Stewardship </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(lll) Data exempt from disclosure under Section </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>2-3.196 of the School Code. </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(mmm) Information prohibited from being disclosed </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>under subsection (e) of Section 1-129 of the Illinois </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>Power Agency Act. </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(nnn) Materials received by the Department of Commerce </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>and Economic Opportunity that are confidential under the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>Music and Musicians Tax Credit and Jobs Act. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(ooo)</code></u><code> </code><strike><code>(nnn)</code></strike><code> Data or information provided pursuant to </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>Section 20 of the Statewide Recycling Needs and Assessment </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(ppp)</code></u><code> </code><strike><code>(nnn)</code></strike><code> Information that is exempt from disclosure </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>under Section 28-11 of the Lawful Health Care Activity </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(qqq)</code></u><code> </code><strike><code>(nnn)</code></strike><code> Information that is exempt from disclosure </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>under Section 7-101 of the Illinois Human Rights Act. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(rrr)</code></u><code> </code><strike><code>(mmm)</code></strike><code> Information prohibited from being </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>disclosed under Section 4-2 of the Uniform Money </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Transmission Modernization Act. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(sss)</code></u><code> </code><strike><code>(nnn)</code></strike><code> Information exempt from disclosure under </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>Section 40 of the Student-Athlete Endorsement Rights Act.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(ttt) Information prohibited from being disclosed </code></u></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <u><code>under Section 30 of the Affordable Drug Manufacturing Act.</code></u><code> </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1907</td><td class="xsl" align="center">- 17 -</td><td class="xsl" align="right">LRB104 10724 BDA 20803 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-36, eff. 6-25-21; 102-237, eff. 1-1-22; </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>102-292, eff. 1-1-22; 102-520, eff. 8-20-21; 102-559, eff. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>8-20-21; 102-813, eff. 5-13-22; 102-946, eff. 7-1-22; </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>102-1042, eff. 6-3-22; 102-1116, eff. 1-10-23; 103-8, eff. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>6-7-23; 103-34, eff. 6-9-23; 103-142, eff. 1-1-24; 103-372, </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>eff. 1-1-24; 103-472, eff. 8-1-24; 103-508, eff. 8-4-23; </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>103-580, eff. 12-8-23; 103-592, eff. 6-7-24; 103-605, eff. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>7-1-24; 103-636, eff. 7-1-24; 103-724, eff. 1-1-25; 103-786, </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>eff. 8-7-24; 103-859, eff. 8-9-24; 103-991, eff. 8-9-24; </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>103-1049, eff. 8-9-24; revised 11-26-24.)</code><br> </td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 97. </code><code>Severability. </code><code>The provisions of this Act are </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>severable under Section 1.31 of the Statute on Statutes.</code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 99. </code><code>Effective date. </code><code>This Act takes effect July 1, </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>2025.</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
